Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 10:58 PM
Study NCT ID:
NCT03889067
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2019-03-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Understanding How Salmonella Typhi Infects Humans (Bottlenecks)
Sponsor:
University of Oxford
Organization:
Study Overview
Official Title:
Exploring the Bottleneck Hypothesis of the Pathogenesis of Bacteraemia in an Ambulatory Outpatient Human Experimental Infection of Salmonella Typhi
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Typhoid fever is an infection caused by the bacteria Salmonella Typhi (S. Typhi). S. Typhi causes disease principally in developing countries where communities do not have access to safe water or adequate sanitation. It is thought to cause illness in approximately 22 million people every year and up to 200,000 deaths, mostly in children. The bacteria are spread when faeces from infected individuals contaminate food and water sources. Symptoms of infection include headache, fever and general aches and pains. If not treated properly typhoid infection can lead to severe complications and even death.
In this study the investigators aim to understand more about the S. Typhi bacteria and how S. Typhi causes a bloodstream infection after it has been ingested and passed into the gut. In spite of the extensive morbidity and mortality associated with bacterial blood stream infections (BSI), comparatively little is known about the pathogenesis. At a time of increasing antimicrobial resistance and a lack of new antimicrobial agents, understanding the pathogenesis of BSI is essential for efforts directed at prevention both of Salmonella Typhi and other bacterial species, particularly those that are restricted to humans.
In this study the investigators aim to understand more about the S. Typhi bacteria and how S. Typhi causes a bloodstream infection after it has been ingested and passed into the gut. In spite of the extensive morbidity and mortality associated with bacterial blood stream infections (BSI), comparatively little is known about the pathogenesis. At a time of increasing antimicrobial resistance and a lack of new antimicrobial agents, understanding the pathogenesis of BSI is essential for efforts directed at prevention both of Salmonella Typhi and other bacterial species, particularly those that are restricted to humans.
Detailed Description:
The pathogenesis of bacteraemia for human restricted pathogens such as Streptococcus pneumoniae, Haemophilus influenzae type b and Salmonella enterica serovar Typhi (ST), have thus far only been investigated in imperfect animal models. The Salmonella Typhimurium mouse model is widely employed however there are key differences compared with S. Typhi. These bacteria are both genetically distinct and cause a different human disease phenotype . Data from a human model would be invaluable in furthering our understanding of bacteraemia in the human host. Animal studies with Salmonella species and other bacterial species show some evidence that there may be population bottlenecks in the development of blood stream infections.
Inoculation with many microorganisms is often sufficient to cause a blood stream infection in a susceptible host, typically inoculation with a single microorganism is not. There are two principle theories as to how bacteraemia arises. The first is independent action whereby the bacteraemia that results from bacterial inoculation is derived from a single founder organism ('the bottleneck hypothesis'). Each organism has a chance of being that founder organism. A greater number of organisms make bacteraemia more likely. The second theory is synergy where there is cooperation between bacteria, multiple bacteria traverse the barrier to infection and therefore the bacteraemia is composed of multiple variants.
The aim of this research project is to investigate the population bottleneck theory in the pathogenesis of bacteraemia in human infection model using a challenge combination of two isogenic strains of S. Typhi.
The primary objective of the study is to compare the number of participants who develop bacteraemia post challenge from each S. Typhi variant or a combination of the two strains. From animal models the investigators hypothesize that in an individual participant a single strain will be isolated more commonly than a combination of the two. The secondary objectives are to quantify the burden of bacteraemia of the two strains and to characterise the stool shedding in participants given a mixed inoculum.
Exploratory objectives include comparison of the number of participants who develop bacteraemia at various timepoints until 72 hours from each S. Typhi variant or a combination of the two strains. From animal models it is expected that any so-called 'primary bacteraemias' may involve a combination of the S. Typhi strains. The researchers also anticipate that stool cultures from study participants may culture a combination of the S. Typhi strains initially but that if a single isolate is cultured from the blood that this will be reflected in stool culture. The investigators will explore if quantitation of S. Typhi is possible in stool. They will also seek to evaluate the host immune response to challenge in terms of cytokine and blood transcriptional signatures.
This is the first time in which the bottleneck theory has been explored in a human model of a bloodstream infection. It will not only be significant for understanding the pathogenesis of S. Typhi but also for other bacterial pathogens. If this hypothesis is supported this implies that the barrier for vaccine prevention of bacterial infection may be lower than previously thought, perhaps only very few or even a single organism must be prevented from invasion to provide individual protection.
Inoculation with many microorganisms is often sufficient to cause a blood stream infection in a susceptible host, typically inoculation with a single microorganism is not. There are two principle theories as to how bacteraemia arises. The first is independent action whereby the bacteraemia that results from bacterial inoculation is derived from a single founder organism ('the bottleneck hypothesis'). Each organism has a chance of being that founder organism. A greater number of organisms make bacteraemia more likely. The second theory is synergy where there is cooperation between bacteria, multiple bacteria traverse the barrier to infection and therefore the bacteraemia is composed of multiple variants.
The aim of this research project is to investigate the population bottleneck theory in the pathogenesis of bacteraemia in human infection model using a challenge combination of two isogenic strains of S. Typhi.
The primary objective of the study is to compare the number of participants who develop bacteraemia post challenge from each S. Typhi variant or a combination of the two strains. From animal models the investigators hypothesize that in an individual participant a single strain will be isolated more commonly than a combination of the two. The secondary objectives are to quantify the burden of bacteraemia of the two strains and to characterise the stool shedding in participants given a mixed inoculum.
Exploratory objectives include comparison of the number of participants who develop bacteraemia at various timepoints until 72 hours from each S. Typhi variant or a combination of the two strains. From animal models it is expected that any so-called 'primary bacteraemias' may involve a combination of the S. Typhi strains. The researchers also anticipate that stool cultures from study participants may culture a combination of the S. Typhi strains initially but that if a single isolate is cultured from the blood that this will be reflected in stool culture. The investigators will explore if quantitation of S. Typhi is possible in stool. They will also seek to evaluate the host immune response to challenge in terms of cytokine and blood transcriptional signatures.
This is the first time in which the bottleneck theory has been explored in a human model of a bloodstream infection. It will not only be significant for understanding the pathogenesis of S. Typhi but also for other bacterial pathogens. If this hypothesis is supported this implies that the barrier for vaccine prevention of bacterial infection may be lower than previously thought, perhaps only very few or even a single organism must be prevented from invasion to provide individual protection.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: